Overloaded RNA 'editing room' reveals weakness in RAS-driven cancers

Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have identified an overworked cog in ...
STAT

The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades

Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...